Ipratop 0.25 Nebuliser Solution
Ipratropium Bromide
0.25 mg/ml
Incepta Pharmaceuticals Ltd.
| Pack size | 10's |
|---|---|
| Unite Price | 180.00 BDT |
Indications
Ipratop 0.25 Nebuliser Solution is used for:
Asthma, chronic obstructive pulmonary disease, chronic bronchitis, emphysema.
Adult Dose
Inhalation
Asthma; Chronic obstructive pulmonary disease
Adult: As Inhaler: Adults: 1-2 puffs (20 mg/puff) 3-4 times daily. Single doses of up to 80 mcg may be required in some patients.
As nebulized soln
250-500 mcg 3-4 times daily.
Child Dose
Inhalation
Asthma; Chronic obstructive pulmonary disease
Child: As metered-dose aerosol:
<6 yr 20 mcg tid;
6-12 yr 20-40 mcg tid.
As soln for nebulisation:
<6 yr For acute asthma: 125-250 mcg, given no more often than 6 hrly up to a total dose of 1 mg.
6-12 yr For acute and chronic asthma: 250 mcg, repeated as necessary up to a total dose of 1 mg.
Renal Dose
Administration
Contra Indications
Ipratropium Bromide solution should not be taken by patients with known hypersensitivity to atropine or its derivatives or to any other component of the product.
Precautions
Bladder neck obstruction, narrow-angle glaucoma or patients susceptible to glaucoma, prostatic hyperplasia. Protect patient's eyes from nebulised drug. Renal and hepatic impairment. Pregnancy, lactation, children, elderly.
Pregnancy-Lactation
Pregnancy category: B
Lactation: Unknown whether drug is excreted in breast milk
Interactions
Increased toxicity with other anticholinergic drugs.
Side Effects
Side effects of Ipratropium Bromide :
Dry mouth, urinary retention, buccal ulceration, paralytic ileus, headache, nausea, constipation, paradoxical bronchospasm, immediate hypersensitivity reactions (urticaria, angioedema), acute angle-closure glaucoma.
Potentially Fatal: Anaphylactic reactions, atrial fibrillation, supraventricular tachycardia.
Mode of Action
Ipratropium bromide blocks the action of acetylcholine at parasympathetic sites in bronchial smooth muscle causing bronchodilation.
Note
Ipratop 0.25 0.25 mg/ml Nebuliser Solution generic name is Ipratropium Bromide. Ipratop 0.25 0.25 mg/ml Nebuliser Solution is manufactured by Incepta Pharmaceuticals Ltd.Ipratop 0.25 is availble in all over Bangladesh.
Mes BD drug index information on Ipratop 0.25 Nebuliser Solution is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Ipratropium Bromide :
Inhaler
Ipramid
20mcg
Beximco Pharmaceuticals Ltd.
Inhaler
Ipramid HFA
20mcg
Beximco Pharmaceuticals Ltd.
Aerosol Inhalation
Iprex
20mcg
Square Pharmaceuticals Ltd.
Respirator Solution
Iprex Respiratory Solution
250mcg/ml
Square Pharmaceuticals Ltd.
Nebuliser Solution
Rinase RS
250mcg/ml
ACI Limited